UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 20, 2015
Accession Number:
0001193125-15-008308
Submission Type:
POS AM
CIK:
0001042074
Company Name:
CymaBay Therapeutics, Inc.
File Number:
333-192617